AstraZeneca
AZN
#45
Rank
HK$2.287 T
Marketcap
HK$737.62
Share price
0.68%
Change (1 day)
47.20%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): HK$23.66

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is HK$23.65. In 2024 the company made an earnings per share (EPS) of HK$17.69 an increase over its 2023 EPS that were of HK$14.96.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$23.6633.75%
2024HK$17.6918.23%
2023HK$14.9681.13%
2022HK$8.26631.03%
2021HK$1.13-88.11%
2020HK$9.51136.89%
2019HK$4.01-39.41%
2018HK$6.62-28.27%
2017HK$9.23-14.37%
2016HK$10.7824.11%
2015HK$8.69127.55%
2014HK$3.82-51.96%
2013HK$7.95-58.95%
2012HK$19.37-32.2%
2011HK$28.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Bristol-Myers Squibb
BMY
HK$23.15-2.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.40-43.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.18 150.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$28.02 18.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
HK$28.88 22.10%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
HK$159.90 576.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.36 243.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$62.79 165.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$85.65 262.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.36 142.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland